BioCentury
ARTICLE | Financial News

Provention raises $64M IPO

July 20, 2018 7:15 PM UTC

Autoimmune and infectious disease company Provention Bio Inc. (NASDAQ:PRVB) raised $63.9 million on July 19 through the sale of 16 million shares at $4 in an IPO underwritten by MDB Capital Group and Dougherty & Co. The offering was conducted on a best efforts basis.

The offering values the company at $149.4 million...

BCIQ Company Profiles

Provention Bio Inc.